Dr. Nagavendra Kommineni’s research primarily focuses on advanced drug delivery systems š, particularly liposomal formulations, nanocarriers, and depot microspheres for targeted therapy. He explores the potential of exosomes and dendrimers in drug delivery, aiming to enhance therapeutic efficacy while minimizing side effects šÆ. His investigations extend to the development of novel formulations for cancer therapy, psoriasis treatment, and overcoming drug resistance in diseases like breast cancer. Through his work, Dr. Kommineni contributes significantly to the advancement of pharmaceutical science, with a particular emphasis on improving patient outcomes through innovative delivery strategies.